💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Neuro Spinal Hospital in Dubai to acquire Accuray Cyberknife and Radixact systems

Published 07/11/2017, 08:17 AM
© Reuters.  Neuro Spinal Hospital in Dubai to acquire Accuray Cyberknife and Radixact systems
ARAY
-
  • Accuray Incorporated (NASDAQ:ARAY) announces that the company is expanding access to its products in the Middle East with the signing of an agreement with the Neuro Spinal Hospital in Dubai, United Arab Emirates, for the acquisition of one CyberKnife M6 System and one Radixact System.
  • The CyberKnife M6 System will be primarily used to treat neurological indications such as arteriovenous malformations and trigeminal neuralgia, and secondarily for extracranial cases such as prostate, lung and spine.
  • The Radixact System will be used to treat breast, head and neck, spine, as well as total marrow irradiation.
  • Now read: Housing And Real Estate News 7-8-2017 (Video)


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.